• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Spectrum Solutions Collaborates with UCLA School of Dentistry

    Kwivik Therapeutics, EirMed Partner to Accelerate Product Commercialization

    Europe Marks its First Successful Remote Robotic-Assisted Coronary Angioplasty

    Twist on Heart Valve Design Boosts Blood Flow, Prevents Clots

    FDA Clears 3D Acellular Dermal Matrix
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    FUTEK Advanced Sensor Technology Inc.

    Creganna Medical, part of TE Connectivity

    Element

    Qosina Corp.

    Concise Engineering
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    PTI Engineered Plastics Inc.

    Unicep

    Qosina Corp.

    FUTEK Advanced Sensor Technology Inc.

    maxon
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA Continues User-Fee Related Reviews Through COVID-19

    FDA is extending response due date for 510(k), PMA, HDE, and De Novo applications by 90 days.

    Related CONTENT
    • Congress Examines Additional COVID-19 Relief and Recent Regulatory Changes
    • Global Central Venous Catheter Market to Surpass $3.06 Billion by 2027
    • FDA Grants Breakthrough Device Designation to Cala Trio
    • Will Industry’s COVID-19 Recovery End Prematurely?
    • COVID Community: How the Pandemic Is Bringing Out the Best in Us
    U.S. Food and Drug Administration04.17.20
    The U.S. Food and Drug Administration’s User Fee programs help us fulfill our mission to protect public health while also helping to accelerate innovation in industry and bring new treatment options to the American public. Throughout this public health emergency, we’ve continued to execute our review activities while responding to the public health needs of the current COVID-19 pandemic.
     
    We continue to perform our user fee review activities and our application review teams across the agency remain focused on their work as we do everything possible to maintain continuity of operations in a very dynamic situation. Part of these actions include looking at ways to use technology and established agreements with our foreign counterparts to minimize impact to applications under review.
     
    On the prescription drugs and biologics side, our Center for Drug Evaluation and Research and our Center for Biologics Evaluation and Research (CBER) staff are working diligently, both to address challenges with the ongoing outbreak and to carry out our on-going duty to safeguard public health while helping to ensure that safe and effective, high-quality drugs and biologics are available to the public. At this time, the New Drug Program, the Generic Drug Program, and the Biologics and Biosimilars Programs are continuing to meet key review program user fee performance goals, approve applications and communicate with applicants. With many staff working on COVID-19 activities, it is possible that we will not be able to sustain our current level of performance indefinitely. Our staffs are working at full capacity and we are striving to ensure that the drug programs continue to see minimal interruptions during this time. However, if there is an increase in drugs shortages and supply disruptions, we will be ready to reprioritize more of this work, as necessary.
     
    On the devices side, our Center for Devices and Radiological Health (CDRH) and CBER continue to meet all of their Medical Device User Fee Amendments (MDUFA) review goals. We have taken steps to contact industry stakeholders to convert each previously scheduled meeting through May to a teleconference. For marketing applications on hold, we are further extending response due dates by 90 days for Premarket Notifications (510(k)s), Premarket Approval (PMA) applications (original and supplements), Humanitarian Device Exemption (HDE) applications (original and supplements) and De Novo classification requests. It is likely this extension of time will have an impact on the FDA and industry’s ability to meet the shared outcome goals for total time to decision as listed in the MDUFA IV commitment letter. Additionally, with many staff in CDRH working on COVID-19 activities related to pre-Emergency Use Authorizations (pre-EUAs), EUAs, and Immediately In Effect (IIE) guidance documents, it is possible that we will not be able to sustain our current level of performance indefinitely. However, this will be assessed on an ongoing basis.
     
    For animal drug and generic animal drug user fee programs, our Center for Veterinary Medicine continues to meet all of its user fee-related performance goals and does not currently anticipate a change in our ability to meet these performance goals during the COVID-19 pandemic. Our staff is currently in a primarily telework environment and is utilizing teleconferencing tools to continue communicating with sponsors in lieu of in-person meetings. To help minimize the potential impact of the COVID-19 pandemic on new animal drug development, we issued guidance for industry stakeholders on the conduct and review of studies to support new animal drug development. We are also closely monitoring the potential for new animal drug shortages and supply chain disruptions, and we are working closely with sponsors to address these challenges, as appropriate.
     
    It is difficult to speculate on what the exact impact will be on incoming submissions moving forward. We are seeing and hearing from industry that companies are taking a role as partners in the defense of the public health by prioritizing their work and submissions.
     
    As this remains an evolving and very dynamic situation, the FDA will continue to be flexible and as transparent as possible as we work to address the COVID-19 pandemic, as well as keep other key mission-critical initiatives unrelated to the pandemic moving forward.
    Related Searches
    • medical
    • change
    • research
    • medical device
    Suggested For You
    Congress Examines Additional COVID-19 Relief and Recent Regulatory Changes Congress Examines Additional COVID-19 Relief and Recent Regulatory Changes
    Global Central Venous Catheter Market to Surpass $3.06 Billion by 2027 Global Central Venous Catheter Market to Surpass $3.06 Billion by 2027
    FDA Grants Breakthrough Device Designation to Cala Trio FDA Grants Breakthrough Device Designation to Cala Trio
    Will Industry’s COVID-19 Recovery End Prematurely? Will Industry’s COVID-19 Recovery End Prematurely?
    COVID Community: How the Pandemic Is Bringing Out the Best in Us COVID Community: How the Pandemic Is Bringing Out the Best in Us
    The Current COVID-19 Environment and Emergency Use Authorizations The Current COVID-19 Environment and Emergency Use Authorizations
    OralDNA Labs Gains EUA for Saline Oral Rinse COVID-19 RT-PCR Test OralDNA Labs Gains EUA for Saline Oral Rinse COVID-19 RT-PCR Test
    Saliva Tests Could Spot Silent COVID-19 Carriers Saliva Tests Could Spot Silent COVID-19 Carriers
    Cepheid Cepheid's Combo COVID-19, Flu A/B, RSV Test Earns EUA
    Hologic Granted EUA for Asymptomatic COVID-19 Testing Hologic Granted EUA for Asymptomatic COVID-19 Testing
    75-Minute Diagnostic Determines COVID Status 75-Minute Diagnostic Determines COVID Status
    FDA Authorizes First Point-of-Care COVID-19 Antibody Test FDA Authorizes First Point-of-Care COVID-19 Antibody Test
    Eurobio Scientific Launches Rapid Dx Test for SARS CoV-2 Virus Antigen Eurobio Scientific Launches Rapid Dx Test for SARS CoV-2 Virus Antigen
    FDA Launches the Digital Health Center of Excellence FDA Launches the Digital Health Center of Excellence
    Acutus AcQMap Catheter Cleared by FDA Acutus AcQMap Catheter Cleared by FDA

    Related Breaking News

    • Diagnostics
      Spectrum Solutions Collaborates with UCLA School of Dentistry

      Spectrum Solutions Collaborates with UCLA School of Dentistry

      Commences study on using saliva in early lung cancer detection and analysis.
      Charles Sternberg, Assistant Editor 01.27.21

    • Kwivik Therapeutics, EirMed Partner to Accelerate Product Commercialization

      Kwivik Therapeutics, EirMed Partner to Accelerate Product Commercialization

      Kwivik has developed a pipeline of products for certain respiratory, emergency medical, asthma, migraine/cluster headache, wound care, and skin care markets.
      Michael Barbella, Managing Editor 01.27.21

    • Europe Marks its First Successful Remote Robotic-Assisted Coronary Angioplasty

      Europe Marks its First Successful Remote Robotic-Assisted Coronary Angioplasty

      The procedure was carried out on an animal model late last year.
      Michael Barbella, Managing Editor 01.27.21


    • Cardiovascular | Surgical
      Twist on Heart Valve Design Boosts Blood Flow, Prevents Clots

      Twist on Heart Valve Design Boosts Blood Flow, Prevents Clots

      UBC Okanagan research could transform the current gold standard for heart valves.
      Sam Brusco, Associate Editor 01.27.21

    • FDA Clears 3D Acellular Dermal Matrix

      FDA Clears 3D Acellular Dermal Matrix

      The technology is supported by more than 150 peer-reviewed published articles.
      Michael Barbella, Managing Editor 01.27.21

    • Inogen to Undergo Leadership Transition

      Inogen to Undergo Leadership Transition

      Longtime BD exec Nabil Shabshab succeeds retiring Scott Wilkinson as president and CEO.
      Sam Brusco, Associate Editor 01.27.21


    • Asia-Pacific Advanced Wound Management Market to Undergo Robust Expansion

      Asia-Pacific Advanced Wound Management Market to Undergo Robust Expansion

      The market is being driven by a global aging population, increasing patient awareness levels, and rising disposable incomes.
      Michael Barbella, Managing Editor 01.27.21

    • Butterfly Network Appoints New Leader

      Butterfly Network Appoints New Leader

      Dr. Todd M. Fruchterman was most recently Flex’s group president of reliability solutions.
      Sam Brusco, Associate Editor 01.26.21

    • BD Names Chairman of Board

      BD Names Chairman of Board

      BD CEO and president, Tom Polen, joins the board.
      Charles Sternberg, Assistant Editor 01.26.21


    • Interplex Acquires OCP Group

      Interplex Acquires OCP Group

      The deal is a strategic investment in expanding Interplex’s Medical & Life Sciences product portfolio.
      Michael Barbella, Managing Editor 01.26.21

    • FDA Clears a Portable Hemodialysis System

      FDA Clears a Portable Hemodialysis System

      Quanta Dialysis Technologies' SC+ system became available in the U.K. last year.
      Michael Barbella, Managing Editor 01.26.21

    • Solid Growth Forecast for India

      Solid Growth Forecast for India's HER2 Amplification Tests Market

      Sector is expected to expand 7 percent annually over the next five years.
      Michael Barbella, Managing Editor 01.26.21


    • Diagnostics
      Abbott

      Abbott's Panbio Rapid COVID-19 Antigen Test Earns CE Mark for Two New Uses

      EU approves symptomatic screening and self-administered sample collection with nasal swab.
      Sam Brusco, Associate Editor 01.26.21

    • $30 Million in New Financing Secured by CathWorks

      $30 Million in New Financing Secured by CathWorks

      The company's FFRangio System is a non-invasive diagnostic technology that is used at the time of a routine angiography.
      Michael Barbella, Managing Editor 01.26.21

    • Cardiovascular
      Alleviant

      Alleviant's Transcatheter Tech Obtains Breakthrough Status

      The technology offers a no-implant interatrial shunt therapy for heart failure patients.
      Sam Brusco, Associate Editor 01.25.21


    Trending
    • Senseonics Forges Strategic Collaboration With Ascensia Diabetes Care
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Henry Schein Buys Majority Interest In Prism Medical Products
    • Top 10 Trends In The Medical Device And Equipment Industry
    • Masimo Earns CE Mark For New Fingertip Pulse Oximeter
    Breaking News
    • Spectrum Solutions Collaborates with UCLA School of Dentistry
    • Kwivik Therapeutics, EirMed Partner to Accelerate Product Commercialization
    • Europe Marks its First Successful Remote Robotic-Assisted Coronary Angioplasty
    • Twist on Heart Valve Design Boosts Blood Flow, Prevents Clots
    • FDA Clears 3D Acellular Dermal Matrix
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    PepsiCo and Beyond Meat Partner to Develop Plant-Based Protein
    New Study on Sage Extract Formula Suggests Memory Enhancement
    Omega-3s Evidenced to Reduce Low-Grade Inflammation in Elderly Men
    Coatings World

    Latest Breaking News From Coatings World

    Mayzo Makes 2 Appointments
    Mississippi Lime Company Announces New Director of Safety
    IFS Coatings Launches IFS Puroplaz PE20 Texture
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Spectrum Solutions Collaborates with UCLA School of Dentistry
    Kwivik Therapeutics, EirMed Partner to Accelerate Product Commercialization
    Europe Marks its First Successful Remote Robotic-Assisted Coronary Angioplasty
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies
    Novartis Invests in Credence MedSystems
    Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Coty to Shut Down Manufacturing Site in Cologne, Germany
    L’Occitane Files for Bankruptcy in U.S.
    Bésame Cosmetics Collaborates with Disney on Mary Poppins Collection
    Happi

    Latest Breaking News From Happi

    CLT Introduces Private Label Solid Air Freshener Cones
    The Florida Sunscreen Symposium Is Back!
    TFF Opens Nominations for 2021 Awards
    Ink World

    Latest Breaking News From Ink World

    Epson Partner Creates Label Applicators for Pharmaceutical Products
    Smurfit Kappa Sets New Sustainability Targets with Better Planet 2050
    Georgia-Pacific Acquires 3rd HP PageWide Corrugated Press to Expand Hummingbird Digital Printing
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Arjobex acquires MDV Group
    Fix-A-Form eyes global expansion
    McCracken Label installs Fujifilm water-wash plate system
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Nice-Pak Receives EPA Approval for Disinfecting Wipes
    Rockline to Invest $18 Million in Arkansas
    Essity’s Sales Negatively Impacted by Covid-19 Pandemic
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ChoiceSpine's Tiger Shark Cervical Spacer Earns Additional 510(k)
    FDA Green Lights Inspired Spine's Trident SI Joint Screw System
    FDA Clears Method to Extract Bone Measurements From X-Rays
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Osram Sees Jump in Profits in Preliminary 2020 Report
    LG Display Reports 4Q 2020 Results
    Xerox Releases 4Q, Full Year Results

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login